Illuminating the Immune System
News May 01, 2013
A team led by Ruslan Medzhitov, professor of immunobiology and a Howard Hughes Medical Institute investigator, found that the body’s ability to tolerate infectious disease pathogens is as important as the immune system’s ability to fight them.
The team’s research, published in Science Express, explored the balance between tolerance and immune response in mice infected with both the influenza virus and legionella pneumophila bacteria, which cause pneumonia. When the mice were given a dose of either the virus or bacteria alone, their bodies fought the infection, and they survived. But when they were given the same doses of both virus and bacteria within three days, and when they received the virus first, all of the mice died. A longer time between the infective disease allowed the mice to survive the subsequent bacterial infection.
Another team led by Richard Flavell, chair and professor of immunobiology, and published in the journal Nature Medicine, discovered markers for the cellular mechanism that can shut down the immune response, leading to diseases that based on immunodeficiency. This finding will help further the understanding of the role of immunosuppression in human disease.
Study Reveals How MRSA Infection Compromises Lymphatic FunctionNews
Infections of the skin or other soft tissues with the hard-to-treat MRSA bacteria appear to permanently compromise the lymphatic system, which is crucial to immune system function. Investigators describe how MRSA infection impairs the ability of lymphatic vessels to pump lymphatic fluid to lymph nodes in mouse models, which may contribute to the frequent recurrences of MRSA infection experienced by patients.
Possible Biomarker to Identify Who Would Benefit from ImmunotherapyNews
While immunotherapy has made a big impact on cancer treatment, the fact remains that only about a quarter of patients respond to these treatments. In a new study, researchers examined tissue samples from melanoma and ovarian cancer patients treated with immunotherapies and found a link between the percentage of antigen-presenting cells expressing PD-L1 and an objective clinical response to treatment.READ MORE
Fight Against Cancer: Drug Combination Helps Kickstart the Immune SystemNews
Scientists from King's College London have found a way to boost the immune system to help it fight back against cancer.
The breakthrough involves the first ever use of a combination of chemotherapy and a drug being trialled as a treatment for neonatal jaundice, that together help kick start the body's natural defences.